Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...

Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is ...

We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...

Oncotelic Therapeutics, a leader in RNA-based therapeutics, is pleased to announce that Vuong Trieu, Ph.D., Chairman & CEO, will be delivering a featured presentation at the SWCR 2025 Conference on ...

A HUSBAND from Christchurch has put into writing the experience of his wife living with Parkinson’s in his debut book. Laurence Phillips lives in the town with his wife Estelle Phillips, who has had ...

Accumulation of fat molecules is detrimental to the cell. Researchers have made a breakthrough in understanding how our cells manage to stay healthy by recycling important fat molecules. Their study ...

For a seamless experience for patients, colonoscopic fecal microbiota transplantation allows for the restoration of gut ...

Air pollution harms cognitive functions by damaging brain cells, reducing oxygen flow, and increasing inflammation, leading ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...